Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS
- PMID: 15242960
- PMCID: PMC440623
- DOI: 10.1128/CDLI.11.4.792-794.2004
Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS
Abstract
The sensitivities and specificities of an immunofluorescence assay and an enzyme immunoassay for detection of antibodies specific for severe acute respiratory syndrome coronavirus (SARS-CoV) were compared for 148 laboratory-confirmed SARS cases. The appearance and persistence of SARS-CoV-specific antibodies were assessed, with immunoglobulin G detected in 59% of samples collected within 14 days and persisting for 60 to 95 days after the onset of illness.
Similar articles
-
Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia.J Clin Microbiol. 2004 May;42(5):2306-9. doi: 10.1128/JCM.42.5.2306-2309.2004. J Clin Microbiol. 2004. PMID: 15131220 Free PMC article.
-
Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.Clin Diagn Lab Immunol. 2004 Jul;11(4):665-8. doi: 10.1128/CDLI.11.4.665-668.2004. Clin Diagn Lab Immunol. 2004. PMID: 15242938 Free PMC article.
-
Serology of severe acute respiratory syndrome: implications for surveillance and outcome.J Infect Dis. 2004 Apr 1;189(7):1158-63. doi: 10.1086/380397. Epub 2004 Mar 16. J Infect Dis. 2004. PMID: 15031782 Free PMC article.
-
[Diagnostic tests: SARS-Corona virus].Nihon Rinsho. 2005 Jul;63 Suppl 7:343-5. Nihon Rinsho. 2005. PMID: 16111269 Review. Japanese. No abstract available.
-
Laboratory diagnosis of SARS.Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1083-9. doi: 10.1098/rstb.2004.1493. Philos Trans R Soc Lond B Biol Sci. 2004. PMID: 15306394 Free PMC article. Review.
Cited by
-
Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?Pathogens. 2020 Sep 9;9(9):739. doi: 10.3390/pathogens9090739. Pathogens. 2020. PMID: 32916812 Free PMC article. Review.
-
Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets.Int J Infect Dis. 2005 Nov;9(6):323-30. doi: 10.1016/j.ijid.2004.07.014. Epub 2005 Aug 10. Int J Infect Dis. 2005. PMID: 16095942 Free PMC article.
-
Optical Biosensors for Virus Detection: Prospects for SARS-CoV-2/COVID-19.Chembiochem. 2021 Apr 6;22(7):1176-1189. doi: 10.1002/cbic.202000744. Epub 2020 Dec 9. Chembiochem. 2021. PMID: 33119960 Free PMC article. Review.
-
Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV).Virol J. 2007 Mar 27;4:32. doi: 10.1186/1743-422X-4-32. Virol J. 2007. PMID: 17386116 Free PMC article.
-
Immune response following infection with SARS-CoV-2 and other coronaviruses: A rapid review.Rev Med Virol. 2021 Mar;31(2):e2162. doi: 10.1002/rmv.2162. Epub 2020 Sep 23. Rev Med Virol. 2021. PMID: 32964627 Free PMC article. Review.
References
-
- Booth, C. M., L. M. Matukas, G. A. Tomlinson, A. R. Rachlis, D. B. Rose, H. A. Dwosh, S. L. Walmsley, T. Mazzulli, M. Avendano, P. Derkach, I. E. Ephtimios, I. Kitai, B. D. Mederski, S. B. Shadowitz, W. L. Gold, L. A. Hawryluck, E. Rea, J. S. Chenkin, D. W. Cescon, S. M. Poutanen, and A. S. Detsky. 2003. Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto area. JAMA 289:1-9. - PubMed
-
- Drosten, C., S. Gunther, W. Preiser, S. van der Werf, H.-R. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, R. A. M. Fouchier, A. Berger, A.-M. Burguiere, J. Cinatl, M. Eickmann, N. Escriou, K. Grywna, S. Kramme, J.-C. Manuguerra, S. Muller, V. Rickerts, M. Sturmer, S. Vieth, H.-D. Klenk, A. D. M. E. Osterhaus, H. Schmitz, and H. W. Doerr. 2003. Identification of a novel virus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:1967-1976. - PubMed
-
- Ksiazek, T. G., D. Erdman, C. S. Goldsmith, S. R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J. A. Corner, W. Lim, P. E. Rollin, K. H. Nghiem, S. Dowell, A.-E. Ling, C. Humphrey, W.-J. Shieh, J. Guarner, C. D. Paddock, P. Rota, B. Fields, J. DeRisi, J.-Y. Yang, N. Cox, J. Hughes, J. W. LeDuc, W. J. Bellini, L. J. Anderson, and the SARS Working Group. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:1953-1966. - PubMed
-
- Kuiken, T., R. A. Fouchier, M. Schutten, G. F. Rimmelzwaan, G. van Amerongen, D. van Riel, J. D. Laman, T. de Jong, G. van Doornum, W. Lim, A. E. Ling, P. K. Chan, J. S. Tam, M. C. Zambon, R. Gopal, C. Drosten, S. van der Werf, N. Escriou, J.-C. Manuguerra, K. Stohr, J. S. Peiris, and A. D. Osterhaus. 2003. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362:263-270. - PMC - PubMed
-
- Lee, N., D. Hui, A. Wu, P. Chan, P. Cameron, G. M. Joynt, A. Ahuja, M. Y. Yung, C. B. Leung, K. F. To, S. F. Lui, C. C. Szeto, S. Chung, and J. J. Y. Sung. 2003. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348:1986-1994. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous